These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 31821572)

  • 1. Treatment sequence and survival in locoregionally advanced hypopharyngeal cancer: A surveillance, epidemiology, and end results-based study.
    Hochfelder CG; McGinn AP; Mehta V; Castellucci E; Kabarriti R; Ow TJ
    Laryngoscope; 2020 Nov; 130(11):2611-2621. PubMed ID: 31821572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Survival analysis of patients with advanced hypopharyngeal cancer comparing patients who received primary surgery to those who received chemoradiation: An analysis of the NCDB.
    Hochfelder CG; Mehta V; Kabarriti R; McGinn AP; Castellucci E; Ow TJ
    Oral Oncol; 2021 Oct; 121():105470. PubMed ID: 34418696
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary Surgery vs Chemoradiation Treatment of Advanced-Stage Hypopharyngeal Squamous Cell Carcinoma.
    Harris BN; Biron VL; Donald P; Farwell DG; Luu QC; Bewley AF; Chen AM; Daly ME
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):636-40. PubMed ID: 25973578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The importance of adjuvant treatment and primary anatomical site in head and neck basaloid squamous cell carcinoma survival: an analysis of the National Cancer Database.
    Gootee J; Patel M; Aurit S; Silberstein P
    Clin Transl Oncol; 2020 Dec; 22(12):2264-2274. PubMed ID: 32440914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant Chemoradiation After Surgical Resection in Elderly Patients With High-Risk Squamous Cell Carcinoma of the Head and Neck: A National Cancer Database Analysis.
    Woody NM; Ward MC; Koyfman SA; Reddy CA; Geiger J; Joshi N; Burkey B; Scharpf J; Lamarre E; Prendes B; Adelstein DJ
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):784-792. PubMed ID: 28602410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncological outcomes from surgical vs. non-surgical treatments for advanced hypopharyngeal squamous cell carcinoma: a surveillance, epidemiology, and end results-based study.
    Fan Y; Li S; Xia X; Yu S; Zhu X; Zhu Y; Diao W; Chen X
    Clin Transl Oncol; 2022 Dec; 24(12):2379-2387. PubMed ID: 35882729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Survival benefit of post-operative chemotherapy for intermediate-risk advanced stage head and neck cancer differs with patient age.
    Chen MM; Colevas AD; Megwalu U; Divi V
    Oral Oncol; 2018 Sep; 84():71-75. PubMed ID: 30115479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Locally advanced hypopharyngeal and laryngeal cancer: Influence of HPV status.
    Bates JE; Morris CG; Hitchcock KE; Dziegielewski PT; Mendenhall WM; Amdur RJ
    Radiother Oncol; 2019 Nov; 140():6-9. PubMed ID: 31174105
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment patterns and survival outcomes of advanced hypopharyngeal squamous cell carcinoma.
    Tsai YT; Chen WC; Chien CY; Hsu CM; Lee YC; Tsai MS; Lin MH; Lai CH; Chang KP
    World J Surg Oncol; 2020 May; 18(1):82. PubMed ID: 32357934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemoradiation does not improve survival in elderly patients with high-risk resected head and neck cancer.
    Giacalone NJ; Qureshi MM; Mak KS; Kirke D; Patel SA; Shah BA; Salama AR; Jalisi S; Truong MT
    Laryngoscope; 2018 Apr; 128(4):831-840. PubMed ID: 28833217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluating Adjuvant Therapy With Chemoradiation vs Radiation Alone for Patients With HPV-Negative N2a Head and Neck Cancer.
    Yan F; Li H; Kaczmar JM; Sharma AK; Day TA; Neskey DM; Pipkorn P; Zenga J; Graboyes EM
    JAMA Otolaryngol Head Neck Surg; 2020 Dec; 146(12):1109-1119. PubMed ID: 32790830
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Definitive Chemoradiotherapy Versus Surgery Followed by Adjuvant Radiotherapy in Resectable Stage III/IV Hypopharyngeal Cancer.
    Kim JW; Kim MS; Kim SH; Kim JH; Lee CG; Kim GE; Keum KC
    Cancer Res Treat; 2016 Jan; 48(1):45-53. PubMed ID: 25779363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing surgical and nonsurgical larynx-preserving treatments with total laryngectomy for locally advanced laryngeal cancer.
    Patel SA; Qureshi MM; Dyer MA; Jalisi S; Grillone G; Truong MT
    Cancer; 2019 Oct; 125(19):3367-3377. PubMed ID: 31206637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Nonsteroidal Anti-inflammatory Drug Use With Survival in Patients With Squamous Cell Carcinoma of the Head and Neck Treated With Chemoradiation Therapy.
    Iovoli AJ; Hermann GM; Ma SJ; Platek AJ; Farrugia MK; Yau E; Wooten KE; Arshad H; Gupta V; Kuriakose MA; Hicks WL; Singh AK
    JAMA Netw Open; 2020 Jun; 3(6):e207199. PubMed ID: 32602907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adjuvant chemoradiotherapy versus with radiotherapy alone for locally advanced salivary gland carcinoma among older patients.
    Tanvetyanon T; Fisher K; Caudell J; Otto K; Padhya T; Trotti A
    Head Neck; 2016 Jun; 38(6):863-70. PubMed ID: 26340707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predicting Factors for Oncological and Functional Outcome in Hypopharyngeal Cancer.
    Visini M; Giger R; Shelan M; Elicin O; Anschuetz L
    Laryngoscope; 2021 May; 131(5):E1543-E1549. PubMed ID: 33098325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A retrospective study on combined modality therapy with or without surgery for advanced hypopharyngeal squamous cell carcinoma: an analysis of 119 cases].
    Zhang YX; Peng HH; Zhang XX; Zhao JD; Wu WM; Wang JL; Huang DL; Zong L; Chen LW; Liu CQ; Liu MB
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2018 May; 53(5):352-358. PubMed ID: 29764016
    [No Abstract]   [Full Text] [Related]  

  • 18. Laryngo-esophageal dysfunction free survival and propensity score matched analysis comparing organ preservation and total laryngectomy in hypopharynx cancer.
    Petersen JF; Arends CR; van der Noort V; Al-Mamgani A; de Boer JP; Stuiver MM; van den Brekel MWM
    Oral Oncol; 2019 Aug; 95():143-149. PubMed ID: 31345382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of concomitant chemoradiation on survival for patients with T1-2N1 head and neck cancer.
    Zumsteg ZS; Kim S; David JM; Yoshida EJ; Tighiouart M; Shiao SL; Scher K; Mita A; Sherman EJ; Lee NY; Ho AS
    Cancer; 2017 May; 123(9):1555-1565. PubMed ID: 28001302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment trends and survival effects of chemotherapy for hypopharyngeal cancer: Analysis of the National Cancer Data Base.
    Kuo P; Sosa JA; Burtness BA; Husain ZA; Mehra S; Roman SA; Yarbrough WG; Judson BL
    Cancer; 2016 Jun; 122(12):1853-60. PubMed ID: 27019213
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.